تفاعل #1726709

ord-764a21ddb1184ccebf879e23a3e47f8b

معادلة التفاعل

O=C1CCNCC1
4-piperidone
CC(=O)Nc1ccc(O)c(C(N)=O)c1
5-acetamido-2-hydroxybenzamide
C1COCCN1
morpholine
O=C1NC2(CCNCC2)Oc2ccccc21
Compound 9
O=C1NC2(CCNCC2)Oc2ccccc21
spiro[2H-1,3-benzoxazin-2,4′-piperidin]-4-(3H)-one

الكواشف

لا شيء

المذيبات

ظروف التفاعل

الظروف التفصيلية
See reaction.notes.procedure_details.

المعالجة

  1. 1
    درجة الحرارةis refluxed for 48 hr
  2. 2
    غسيلwashed with water, brine
  3. 3
    تجفيفdried over Na2SO4
  4. 4
    أخرىAfter solvent removal by rotoevaporation
  5. 5
    أخرىthe crude product is purified by preparative TLC

الإجراء التجريبي

A mixture of 24 mg (0.077 mmol) of N-[4,8-dimethoxyquinoline-2-yl)carbonyl]-4-piperidone, 15 mg (0.077 mmol) of 5-acetamido-2-hydroxybenzamide, and 0.020 mL of morpholine in 3 mL of methanol is refluxed for 48 hr. The reaction mixture is diluted with ethyl acetate, and washed with water, brine, and dried over Na2SO4. After solvent removal by rotoevaporation, the crude product is purified by preparative TLC to give 11 mg (0.022 mmol, 30% yield) of 6-acetamido-1′-[4,8-dimethoxyquinoline-2-yl)carbonyl]spiro[2H-1,3-benzoxazin-2,4′-piperidin]-4-(3H)-one (Compound 9): 1H NMR (DMSO-d6): δ 2.02 (s, 3H), 3.95 (s, 3H), 4.06 (s, 3H), 7.03 (d, 1H), 8.19 (s, 1H), 7.24 (d of d, 1H), 7.52 (d of d, 1H), 7.67 (m, 2H), 8.02 (d, 1H), 8.82, (s, 1H) and 9.98 ppm (s, 1H). MS m/z: 491.1 (M+H)+, 513.2 (M+Na)+.

المصدر

DOI: 10.6084/m9.figshare.5104873.v1براءة الاختراع: US08110570B2uspto-grants-2012_02